Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
443
-
Total 13F shares, excl. options
-
88.4M
-
Shares change
-
+324K
-
Total reported value, excl. options
-
$10.5B
-
Value change
-
+$38.6M
-
Put/Call ratio
-
0.69
-
Number of buys
-
210
-
Number of sells
-
-200
-
Price
-
$119.10
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q1 2019
509 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q1 2019.
DEXCOM INC - Common Stock (DXCM) has 443 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88.4M shares
of 392M outstanding shares and own 22.58% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.63M shares), FMR LLC (6.78M shares), BlackRock Inc. (5.25M shares), BAILLIE GIFFORD & CO (4.92M shares), MORGAN STANLEY (4.76M shares), JPMORGAN CHASE & CO (4.56M shares), Capital World Investors (3.19M shares), BROWN ADVISORY INC (2.71M shares), STATE STREET CORP (1.93M shares), and JANUS HENDERSON GROUP PLC (1.45M shares).
This table shows the top 443 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.